2017 Annual Meeting

Hans Popper Hepatopathology Society

March 5 2017, 8:30am to 12:00pm


Hans Popper Hepatopathology Society

Major Challenges in Liver Pathology

Sunday, March 5, 2017
8:30 AM 12:00 PM
CC 225

Session Credits: 3 CME and 3 SAMs

Moderator: Michael Torbenson, MD, Mayo Clinic, Rochester, MN

Course Description:
The mission of the Hans Popper Hepatopathology Society is to increase knowledge about the normal and diseased liver, with a special emphasis on the role of hepatopathology in clinical care. This session focuses on 6 big problematic areas in liver pathology. In fact, these problem areas represent some of the most common reasons for submitting cases for liver pathology consultation.

Upon completion of this educational activity, participants should be able to:

  • Describe the histological features of emerging hepatic viruses; the best approach to classifying metastatic tumors; the key histological findings of noncirrhotic portal hypertension
  • Identify the histological findings used to diagnose and classify lymphomas of the liver; histological and clinical clues to possible etiologies in cryptogenic cirrhosis; key histological findings that distinguish steatosis from steatohepatitis


8:30 AM

Cryptogenic Cirrhosis: An Approach to the Diagnosis in the Era of Molecular Pathology
Dhanpat Jain, MD, Yale University School of Medicine, New Haven, CT

9:00 AM

Beyond A, B and C: Other Infections of the Liver
Venancio Alves, University of Sao Paulo School of Medicine, Sao Paulo, Brazil

9:30 AM

Metastatic Disease of the Liver: A Common Sense Approach to a Common Problem
Larry Burgart, MD, University of Minnesota College of Medicine, Abbott NW Hospital Minneapolis, MN

10:00 AM

Hepatic Lymphoma Diagnosis, an Algorithmic Approach
Ryan M. Gill, MD, PhD, University of California, San Francisco, San Francisco, CA

10:30 AM


11:00 AM

Idiopathic Noncirrhotic Portal Hypertension
Isabel Fiel, MD, Icahn School of Medicine at Mount Sinai, New York, NY

11:30 AM

Steatosis Versus Steatohepatitis: Some Clarity on Controversies
David Kleiner, MD, PhD, National Cancer Institute, Bethesda, MD


view more